Walgreens Boots Alliance Stock News

Tommy Tuberville, a Republican Senator from the state of Alabama, disclosed 19 new stock trades on April 15th, and one trade in particular is causing big movements in the underlying stock.

Walgreens (NASDAQ: WBA ) layoffs are a hot topic on Thursday after the pharmacy company announced plans to cut jobs! The latest statement notes that Walgreens isn't revealing the number of employees w

Walgreens (WBA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Want retirement to come a few years earlier than you'd planned? Or are you ready to retire now, but want an extra set of eyes on your finances?

If you're on the hunt for overlooked stocks to buy, look no further. Below is a carefully chosen list of seven underappreciated treasures, all full of unrealized potential and ready to cause a stir on

Walgreens has invested billions into primary care in recent years. The company is offering in-person assistance and guidance to patients.

In February, JPMorgan Chase (NYSE: JPM ) CEO Jamie Dimon unloaded $150 million of his company's stock – his first-ever sale. Shares of the bank had risen 70% since 2022, and valuations were beginnin

Walgreens cut its dividend this year. The company's latest earnings numbers weren't great because even without impairment charges, Walgreens would still have reported a loss.

Many investors closely monitor insider buys, as they can provide meaningful insight into the longer-term picture of a company. And recently, they've been deploying cash for these five stocks.

Walgreens (WBA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Momentum has been driving the market, led by artificial intelligence stocks, with the S&P 500 up 10% for the first quarter. However, the markets have started broadening, with financials, industrials a

Walgreens stock trades for less than 6 times forward earnings. The company recently narrowed its outlook for the year, and TD Cowen sees these targets as achievable.

Zacks Retail-Pharmacies and Drug Stores industry players like CVS and WBA are likely to gain despite reimbursement challenges that are hurting the overall health industry. HLF might face the wrath of

Walgreens recently reported its Q2'24 results (fiscal ends in August), with revenue and earnings exceeding the street expectations. The company reported revenue of $37.1 billion and adjusted earnings

Three well-known companies stand out among the market's complexity as excellent opportunities for investors looking for significant gains. Each company operates in the broad domains of pharmaceuticals